These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Lorazepam and scopolamine: A single-dose comparison of effects on human memory and attentional processes. Mintzer MZ; Griffiths RR Exp Clin Psychopharmacol; 2003 Feb; 11(1):56-72. PubMed ID: 12622344 [TBL] [Abstract][Full Text] [Related]
5. Models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on memory, psychomotor performance and mood. Curran HV; Schifano F; Lader M Psychopharmacology (Berl); 1991; 103(1):83-90. PubMed ID: 2006245 [TBL] [Abstract][Full Text] [Related]
6. Physostigmine challenge before and after chronic cholinergic blockade in elderly volunteers. Dukoff R; Wilkinson CW; Lasser R; Friz J; Conway A; Bahro M; Peskind ER; Sunderland T Biol Psychiatry; 1999 Jul; 46(2):189-95. PubMed ID: 10418693 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological evaluation of the cholinergic system in progressive supranuclear palsy. Litvan I; Blesa R; Clark K; Nichelli P; Atack JR; Mouradian MM; Grafman J; Chase TN Ann Neurol; 1994 Jul; 36(1):55-61. PubMed ID: 8024262 [TBL] [Abstract][Full Text] [Related]
8. Differential effects of scopolamine and lorazepam on working memory maintenance versus manipulation processes. Mintzer MZ; Griffiths RR Cogn Affect Behav Neurosci; 2007 Jun; 7(2):120-9. PubMed ID: 17672383 [TBL] [Abstract][Full Text] [Related]
9. Scopolamine but not lorazepam modulates face repetition priming: a psychopharmacological fMRI study. Thiel CM; Henson RN; Dolan RJ Neuropsychopharmacology; 2002 Aug; 27(2):282-92. PubMed ID: 12093602 [TBL] [Abstract][Full Text] [Related]
10. Modulation of mood and cognitive performance following acute administration of single doses of Melissa officinalis (Lemon balm) with human CNS nicotinic and muscarinic receptor-binding properties. Kennedy DO; Wake G; Savelev S; Tildesley NT; Perry EK; Wesnes KA; Scholey AB Neuropsychopharmacology; 2003 Oct; 28(10):1871-81. PubMed ID: 12888775 [TBL] [Abstract][Full Text] [Related]
13. Scopolamine induces impairments in the recognition of human facial expressions of anger and disgust. Kamboj SK; Curran HV Psychopharmacology (Berl); 2006 May; 185(4):529-35. PubMed ID: 16555061 [TBL] [Abstract][Full Text] [Related]
14. Scopolamine effects on memory, language, visuospatial praxis and psychomotor speed. Flicker C; Serby M; Ferris SH Psychopharmacology (Berl); 1990; 100(2):243-50. PubMed ID: 2305013 [TBL] [Abstract][Full Text] [Related]
15. Scopolamine and lorazepam exert different patterns of effects in a test battery assessing stages of information processing. Duka T; Redemann B; Voet B Psychopharmacology (Berl); 1995 Jun; 119(3):315-24. PubMed ID: 7675968 [TBL] [Abstract][Full Text] [Related]
16. Estrogen replacement attenuates effects of scopolamine and lorazepam on memory acquisition and retention. Gibbs RB; Burke AM; Johnson DA Horm Behav; 1998 Oct; 34(2):112-25. PubMed ID: 9799622 [TBL] [Abstract][Full Text] [Related]
17. Hypersensitivity to scopolamine in the elderly. Flicker C; Ferris SH; Serby M Psychopharmacology (Berl); 1992; 107(2-3):437-41. PubMed ID: 1615141 [TBL] [Abstract][Full Text] [Related]
18. Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model. Molchan SE; Martinez RA; Hill JL; Weingartner HJ; Thompson K; Vitiello B; Sunderland T Brain Res Brain Res Rev; 1992; 17(3):215-26. PubMed ID: 1467811 [TBL] [Abstract][Full Text] [Related]
19. Age-related decline in central cholinergic function demonstrated with scopolamine. Tariot PN; Patel SV; Cox C; Henderson RE Psychopharmacology (Berl); 1996 May; 125(1):50-6. PubMed ID: 8724448 [TBL] [Abstract][Full Text] [Related]